» Authors » Naziye Ak

Naziye Ak

Explore the profile of Naziye Ak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 100
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dulgar O, Turker S, Basaran G, Araz M, Sumbul A, Caglayan D, et al.
J Chemother . 2024 Jun; :1-7. PMID: 38904164
We aimed to evaluate the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab plus trastuzumab and taxane. We reviewed the medical records...
2.
Ak N, Tuz Z, Aydin E, Ferhatoglu F, Sari M, Paksoy N, et al.
Turk J Med Sci . 2024 May; 54(1):229-238. PMID: 38812646
Background/aim: The study is aimed to determine the relationship between the delivery and breastfeeding history of the patients and the clinicopathological properties of breast cancer. Materials And Methods: A questionnaire...
3.
Minareci Y, Ak N, Sozen H, Tosun O, Kucukgergin C, Aydin F, et al.
Mol Biol Rep . 2024 Apr; 51(1):515. PMID: 38622482
Aim: Epithelial ovarian cancer (EOC) is the most ominous tumor of gynecological cancers due to its poor early detection rate and unfavorable prognosis. To date, there is no reliable screening...
4.
Kayan Tapan T, Celebi F, Yaghouti K, Agacayak F, Ilgun S, Soybir G, et al.
Eur J Breast Health . 2024 Apr; 20(2):117-121. PMID: 38571683
Objective: Differences in individual muscle/fat volumes may change the effectiveness of chemotherapy. In this study, the relationship between trunkal muscle and fat volume and body mass index (BMI) obtained before...
5.
Kurt S, Ilgun A, Ozkurt E, Soybir G, Alco G, Unal C, et al.
World J Surg Oncol . 2024 Mar; 22(1):82. PMID: 38519998
Background: Surgery remains a priority for breast cancer treatment. This study aimed to compare the cosmetic outcomes of oncoplastic patients who had undergone breast-conserving surgery, mini-LDF (latissimus dorsi flap), and...
6.
Minareci Y, Ak N, Tosun O, Sozen H, Saip P, Topuz S, et al.
J Cancer Res Ther . 2024 Feb; 19(Suppl 2):S523-S529. PMID: 38384014
Objective: Central nervous system (CNS) metastasis originating from gynecological cancer is a very rare and late manifestation of the disease. Therefore, there is still limited data on prognostic factors for...
7.
Dogan I, Aydin E, Ak N, Ozkurt S, Ibis K, Sukruoglu O, et al.
J Cancer Res Ther . 2024 Feb; 19(7):1887-1892. PMID: 38376293
Background: The goal of this study was to assess the clinicopathologic characteristics and prognostic variables in men with breast cancer (BC). Methods: Clinical features, pathological characteristics, stage at diagnosis, and...
8.
Unal C, Azizy A, Karabulut S, Tastekin D, Akyildiz A, Yasar S, et al.
Oncologist . 2023 Sep; 28(10):875-884. PMID: 37676712
Introduction: This study aims to report the efficacy and safety of capecitabine plus temozolomide (CAPTEM) across different lines of treatment in patients with metastatic neuroendocrine tumors (NETs). Methods: We conducted...
9.
Unal C, Ozmen T, Ilgun A, Ordu C, Ozkurt E, Ak N, et al.
Breast Cancer (Dove Med Press) . 2023 Sep; 15:659-669. PMID: 37674872
Background: The minichromosome maintenance protein-2 (MCM-2) is a more sensitive proliferation marker than Ki-67. This study aimed to evaluate the relationship between MCM-2 and Oncotype DX recurrence score (ODX-RS) and...
10.
Dogan I, Aydin E, Khanmammadov N, Paksoy N, Ferhatoglu F, Ak N, et al.
J Cancer Res Clin Oncol . 2023 Aug; 149(16):14833-14841. PMID: 37594533
Background: We evaluated the outcomes, and risk factors for recurrence in patients with early stage node-negative breast cancer in this study. Method: Retrospective data analysis was done on patient treatment...